Menu Back toRound Table Discussion: Patient-Focused Benefit-Risk Assessment and Risk Management: Methodology for Engaging with Patients: What has been Learned?

DIA 2021 Global Annual Meeting


Round Table Discussion: Patient-Focused Benefit-Risk Assessment and Risk Management: Methodology for Engaging with Patients: What has been Learned?

Session Chair(s)

Mary  Murray, MBA, MS

Mary Murray, MBA, MS

  • Vice President, Collaborative Action Networks
  • National Minority Quality Forum, United States
Join DIA Patient Engagement Community for a round table discussion tied to session #310 SL Patient-Focused Benefit-Risk Assessment and Risk Management: Methodology for Engaging with Patients: What has been Learned? scheduled for Wednesday, June 30 3-4 PM EDT. Space is limited. When the virtual room is full, attendees attempting to access the session will receive a message noting that the session has reached maximum capacity.

Speaker(s)

Theresa  Mullin, PhD

Theresa Mullin, PhD

  • Associate Director for Strategic Initiatives, CDER
  • FDA, United States
François  Houyez

François Houyez

  • Information and Access Director, Health Policy Advisor
  • European Organisation for Rare Diseases (EURODIS), France
Lembit  Rago, DrMed, MD, PhD

Lembit Rago, DrMed, MD, PhD

  • Secretary General
  • Council for International Organizations of Medical Sciences (CIOMS), Switzerland
Juan  Garcia-Burgos, MD, PhD

Juan Garcia-Burgos, MD, PhD

  • Head of Public and Stakeholders Engagement
  • European Medicines Agency, Netherlands
Talia  Lacroix, MPA

Talia Lacroix, MPA

  • Senior Policy Analyst, Health Product and Food Branch
  • Health Canada, Canada